IP Library Granted Patent US 8,105,380
Granted Patent B2
US 8,105,380 · App. 11/616,787 · Granted Jan 31, 2012

Cellular scaffold

Assignee: Stemedica Cell Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,105,380
App. No.
11/616,787
Granted
Jan 31, 2012
Kind
B2
Abstract

A cellular scaffold that is suitable for tissue regeneration, cell culture and in vitro assays. The invention relates to a layered cell scaffold that is seeded with mesenchymal and ectodermal cells. The layered cellular scaffold comprises an inoculum of mesenchymal cells and ectodermal cells positioned between two opposing scaffolds in a sandwich configuration. The layered cell scaffold provides a functional skin equivalent that is suitable for transplantation and in vitro cell-based assays.

Claims (49)

1. A cellular scaffold arrangement comprising:

a first collagen cell scaffold having a first surface and a second surface wherein said second surface of said first cell scaffold is seeded with mesenchymal cells; and

a second collagen cell scaffold having a first surface and a second surface wherein said first surface of said second cell scaffold is seeded with ectodermal cells;

wherein said second surface of said first scaffold is in contact with said first surface of said second scaffold;

wherein said second cell scaffold has the consistency of a sponge.

2. The cellular scaffold-of claim 1 , wherein said first cell scaffold has a consistency selected from a sponge, a membrane, a gel, and combinations thereof.

3. The cellular scaffold of claim 1 , wherein said mesenchymal cells are derived from at least one of umbilical cord blood, placenta, bone marrow and peripheral blood.

4. The cellular scaffold of claim 1 , wherein said mesenchymal cells comprise fibroblasts.

5. The cellular scaffold of claim 1 , wherein said ectodermal cells comprise precursor keratinocytes.

6. The cellular scaffold of claim 1 , wherein said ectodermal cells are derived from basal keratinocytes.

7. The cellular scaffold of claim 5 , wherein said precursor keratinocytes are inhibited in collagenase production.

8. A layered cellular scaffold comprising:

a first collagen cellular scaffold having a contacting surface that is seeded with a plurality of cells comprising ectodermal cells;

a second collagen cellular scaffold having a contacting surface that is seeded with mesenchymal cells; and

a scaffold interface wherein said first scaffold contacting surface substantially contacts said second scaffold contacting surface;

wherein said first cellular scaffold has the consistency of a sponge.

9. The layered cellular scaffold of claim 8 , wherein said second cellular scaffold has a consistency selected from a sponge, a membrane, a gel, and combinations thereof.

10. The layered cellular scaffold of claim 8 , wherein said mesenchymal cells are derived from at least one of umbilical cord blood, placenta, bone marrow and peripheral blood.

11. The layered cellular scaffold of claim 8 , wherein said mesenchymal cells comprise fibroblasts.

12. The layered cellular scaffold of claim 8 , wherein said ectodermal cells comprise precursor keratinocytes.

13. The layered cellular scaffold of claim 8 , wherein said ectodermal cells are derived from basal keratinocytes.

14. The layered cellular scaffold of claim 12 , wherein said precursor keratinocytes are inhibited in collagenase production.

15. A method of making a layered cellular scaffold comprising:

providing a first cell substrate having a first surface and a second surface;

seeding said second surface of said first cell substrate with ectodermal cells;

providing a second cell substrate having a first surface and a second surface;

seeding said first surface of said second cell substrate with mesenchymal cells; and

contacting said second surface of said first cell substrate with said first surface of said second cell substrate thereby producing said layered cellular scaffold;

wherein said first and second cell substrates comprise collagen; and

wherein said first cell substrate has the consistency of a sponge.

16. The method of claim 15 , wherein said second cell substrate has a consistency selected from a sponge, a membrane, a gel, and combinations thereof.

17. The method of claim 15 , wherein said mesenchymal cells are derived from at least one of umbilical cord blood, placenta, bone marrow and peripheral blood.

18. The method of claim 15 , wherein said mesenchymal cells are fibroblasts.

19. The method of claim 15 , wherein said ectodermal cells are precursor keratinocytes.

20. The method of claim 15 , wherein said ectodermal cells are derived from basal keratinocytes.

21. The method of claim 19 , wherein said precursor keratinocytes are inhibited in collagenase production.

22. A method for making a layered cellular scaffold comprising:

providing a first cell scaffold and a second cell scaffold;

seeding a surface of said first cell scaffold with mesenchymal cells;

seeding a surface of said second cell scaffold with ectodermal cells; and

substantially joining said seeded surfaces to create said layered cellular scaffold;

wherein said first and said second cell scaffolds comprise collagen; and

wherein said second cell scaffold has the consistency of a sponge.

23. The method of claim 22 , wherein said first cell scaffold has a consistency selected from a sponge, a membrane, a gel, and combinations thereof.

24. The method of claim 22 , wherein said mesenchymal cells are derived from at least one of umbilical cord blood, placenta, bone marrow and peripheral blood.

25. The method of claim 22 , wherein said mesenchymal cells are fibroblasts.

26. The method of claim 22 , wherein said ectodermal cells are precursor keratinocytes.

27. The method of claim 22 , wherein said ectodermal cells are derived from basal keratinocytes.

28. The method of claim 26 , wherein said precursor keratinocytes are inhibited in collagenase production.

Assignments (3)
SECURITY INTEREST Recorded Dec 15, 2022
From: STEMEDICA CELL TECHNOLOGIES, INC
To: KINSELLA CONSULTING & INVESTMENTS, LLC
Reel/Frame 062137/0080 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2017
From: KHARAZI, LUDMILLA; KHARAZI, ALEX
To: STEMEDICA CELL TECHNOLOGIES, INC.
Reel/Frame 044024/0159 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2011
From: KHARAZI, ALEX
To: STEMEDICA CELL TECHNOLOGIES, INC.
Reel/Frame 027002/0758 →
Continuity (2)
Provisional Application 60854059 · Oct 23, 2006
Related Publication 20080095748A1 · Apr 24, 2008